What this page clarifies
- Screens scientific claims before business development language.
- Maps regulatory, ethics, and cultural-readiness gaps.
- Creates investor and partner narratives that remain medically cautious.
Questions to ask before moving forward
- Which jurisdiction and regulatory path applies?
- What evidence stage supports the proposition?
- Which ethics and source documents should be ready before launch?
Recommended pathway
- Landscape and claim audit.
- Partner and lab screening.
- Launch narrative with clinical caution and cultural review.